by Mac Slavo, SHTF Plan:

When the FDA announced that new COVID-19 vaccines addressing more recent variants of the virus were available last month, they left out one very important detail: like their predecessors, they were never officially established as being safe or even effective.

How did they get away with it this time around? Much like the first COVID-19 vaccines, they took advantage of the “emergency use authorization” power that enables them to use a lower level of evidence than the traditional threshold for proving effectiveness in FDA product approvals. It essentially means that proving that they “may be effective” is justification enough to flood the market with these untested jabs.